Breathing Life Into COPD Management
Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care
Guidelines
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017.
The COPD Foundation Pocket Consultant Guide
COPD Foundation Guide to COPD Diagnosis and Treatment (Rennard S, et al. COPD. 2013;10(3):378-389).
Patient Resources
American College of Chest Physicians (CHEST Foundation)
The mission of CHEST Foundation is to develop resources to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research.
American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research.
COPD Action Plan
Patients and health care providers should complete this action plan together. This plan should be discussed at each follow-up visit and updated as needed.
COPD Foundation
The COPD Foundation’s mission is to prevent and cure chronic obstructive pulmonary disease and to improve the lives of all people affected by COPD.
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
GOLD partners with health care professionals and public health officials to raise awareness of COPD and to improve prevention and treatment of this lung disease for patients around the world.
National Jewish Health
National Jewish Health is at the forefront of research and medicine, integrating the latest scientific discoveries with coordinated care for lung, heart, and immune diseases. Online instructional videos demonstrate how to properly use inhaled medications for lung diseases.
Clinical Assessment Tools
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Bestall JC, et al. Thorax. 1999;54(7):581-586.
Development and first validation of the COPD Assessment Test.
Jones PW, et al. Eur Respir J. 2009;34(3):648-654.
Suggested Readings
Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.
Decramer M, et al. Lancet Respir Med. 2014;2(6):472-486.
Susceptibility to exacerbation in chronic obstructive pulmonary disease.
Hurst JR, et al. N Engl J Med. 2010;363(12):1128-1138.
Effect of early follow-up after hospital discharge on outcomes in patients with heart failure or chronic obstructive pulmonary disease: a systematic review.
Health Quality Ontario. Ont Health Technol Assess Ser. 2017;17(8):1-37.
Influence of COPD Assessment Text (CAT) evaluation and rehabilitation education guidance on the respiratory and motor functions of COPD patients.
Liu J, et al. Open Med (Wars). 2015;10(1):394-398.
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
Mahler DA, et al. Thorax. 2012;67(9):781-788.
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
Martinez FJ, et al. Lancet. 2015;385(9971):857-866.
Factors affecting chronic obstructive pulmonary disease early rehospitalization.
Nantsupawat T, et al. Chron Respir Dis. 2012;9(2):93-98.
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.
Puhan MA, et al. Cochrane Database Syst Rev. 2016;12:CD005305.
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.
Schnell K, et al. BMC Pulm Med. 2012;12:26.
Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease.
Sharma G, et al. Arch Intern Med. 2010;170(18):1664-1670.
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.
Spruit MA, et al. Am J Respir Crit Care Med. 2013;188(8):e13-e64.
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.
Yawn BP, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:495-502.
Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.
Yawn BP, Thomashow B. Int J Gen Med. 2011;4:665-676.
Interactive PresentationPatient Interview
Barbara P. Yawn, MD, MSc, FAAFP
Module 2 of 4
Relevant Resources
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Improving Outcomes for Patients with COPD
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A New Era in Precision Medicine
Evolving Best Practices to Optimize Outcomes
Consensus and Controversies on the Road to Precision Medicine
Debates and Discussions About Personalizing Patient Management
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
From Guideline Recommendations to Daily Clinical Decision-Making
Improving Patient Outcomes Through Shared Clinical Decision Making
Improving Patient Outcomes Through Shared Clinical Decision Making
Digging Deep on Shared Decision-Making
Clinical Resource Center
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
Mechanistic Insights and Emerging Treatment Options
A Focus on Exacerbation Prevention
Best Practices for Primary Care
Evolving Best Practices for Patient Management
Shared Decision-making in the Era of Biologics
New Pathways to Patient Management
From Comprehensive Patient Evaluations to Individualized Evidence-based Care
Preventing COPD Exacerbations to Improve Outcomes
A Whole Patient Case Series
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
New Avenues to the Management of Severe Asthma
Evolving Best Practices for Pediatric Patients
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
Reducing LDL-C and a Lifetime of Cardiovascular Risk
A Multidisciplinary Look at Early Diagnosis and Management
Finding the Path in Chronic Rhinosinusitis with Nasal Polyps
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
Best Practices for Diagnosis and Management
New Avenues to Pre-Exposure Prophylaxis
New Pathways to Optimize Patient Outcomes
Debates and Discussions About New Upstream Treatment Avenues
A Case-Based Update on Pediatric Patients
